Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia. [electronic resource]
- International journal of cancer Dec 2006
- 2651-6 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
0020-7136
10.1002/ijc.22243 doi
Adult Aged Aged, 80 and over Biomarkers, Tumor--metabolism Colorectal Neoplasms--diagnosis Enzyme-Linked Immunosorbent Assay Feces--enzymology Female Humans Male Middle Aged Prospective Studies Pyruvate Kinase--metabolism Sensitivity and Specificity